In 2014, Lord Saatchi launched his ultimately unsuccessful Medical Innovation Bill in the UK. Its laudable aim was to free doctors from the shackles that prevented them from providing responsible innovative treatment. Lord Saatchi’s principal contention was that current law was the unsurmountable barrier that prevented clinicians from delivering innovative treatments to cancer patients when conventional options had failed. This was because doctors feared that they might be sued or tried and convicted of gross negligence manslaughter if they deviated from standard practice. Concerns about fear of the law and potential negative effects on medical practice are not new. Fear of litigation has been suggested as the reason for doctors practising ...
The focus of the debates surrounding the Medical Innovation Bill and Access to Medical Treatments (I...
The focus of the debates surrounding the Medical Innovation Bill and Access to Medical Treatments (I...
Dr. Jacoby explains why emerging technologies must be evaluated expeditiously. He also argues that a...
open access articleIn 2014, Lord Saatchi launched his ultimately unsuccessful Medical Innovation Bil...
In 2014, Lord Saatchi launched his ultimately unsuccessful Medical Innovation Bill in the UK. Its la...
The current debate surrounding the Medical Innovation Bill purports to be aimed at improving the nor...
Objective: This paper aims to demonstrate that any suggestion that there is a need for specific inno...
This thesis has proposed a fourth model of contact between patient and doctor, that of innovation. T...
This special issue features papers culminating from a six seminar ESRC series ‘Liability versus inno...
From the late nineteenth century onwards there emerged an increasingly diverse response to escalatin...
Lord Saatchi’s Medical Innovation Bill, which has been reintroduced into parliament, is a deeply fla...
Fear of malpractice actions against them is causing physicians to run scared. Some physicians now ...
Alawyer today can hardly speak to a doctor--or even be treated by one-without being assailed by lawy...
This paper explores the interaction of British medical practitioners with the nascent intellectual p...
This article examines the implications of the foregoing competing claims from a U.S. legal perspecti...
The focus of the debates surrounding the Medical Innovation Bill and Access to Medical Treatments (I...
The focus of the debates surrounding the Medical Innovation Bill and Access to Medical Treatments (I...
Dr. Jacoby explains why emerging technologies must be evaluated expeditiously. He also argues that a...
open access articleIn 2014, Lord Saatchi launched his ultimately unsuccessful Medical Innovation Bil...
In 2014, Lord Saatchi launched his ultimately unsuccessful Medical Innovation Bill in the UK. Its la...
The current debate surrounding the Medical Innovation Bill purports to be aimed at improving the nor...
Objective: This paper aims to demonstrate that any suggestion that there is a need for specific inno...
This thesis has proposed a fourth model of contact between patient and doctor, that of innovation. T...
This special issue features papers culminating from a six seminar ESRC series ‘Liability versus inno...
From the late nineteenth century onwards there emerged an increasingly diverse response to escalatin...
Lord Saatchi’s Medical Innovation Bill, which has been reintroduced into parliament, is a deeply fla...
Fear of malpractice actions against them is causing physicians to run scared. Some physicians now ...
Alawyer today can hardly speak to a doctor--or even be treated by one-without being assailed by lawy...
This paper explores the interaction of British medical practitioners with the nascent intellectual p...
This article examines the implications of the foregoing competing claims from a U.S. legal perspecti...
The focus of the debates surrounding the Medical Innovation Bill and Access to Medical Treatments (I...
The focus of the debates surrounding the Medical Innovation Bill and Access to Medical Treatments (I...
Dr. Jacoby explains why emerging technologies must be evaluated expeditiously. He also argues that a...